Ritter Pharmaceuticals Inc. (RTTR)

2.01
0.04 1.95
NASDAQ : Health Technology
Prev Close 2.05
Open 2.07
Day Low/High 2.00 / 2.07
52 Wk Low/High 1.83 / 6.47
Volume 76.61K
Avg Volume 112.80K
Exchange NASDAQ
Shares Outstanding 5.02M
Market Cap 10.64M
EPS -5.00
Div & Yield N.A. (N.A)

Latest News

Ritter Pharmaceuticals Changing the Game With Lactose Intolerance Treatment

Ritter Pharmaceuticals Changing the Game With Lactose Intolerance Treatment

About 40 million people suffer from lactose intolerance in America. If Ritter Pharmaceuticals has any say, that number will soon be zero.

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering big breakouts.

3 Biotech Stocks Under $10 to Trade for Big Breakouts

3 Biotech Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering breakout trades.

Ritter Pharmaceuticals Provides Third Quarter 2015 Financial Results And Business Update

Ritter Pharmaceuticals Provides Third Quarter 2015 Financial Results And Business Update

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal...

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering big breakout trades.

Ritter Pharmaceuticals Appoints AnnKatrin Petersen-Jappelli, M.D., M.SC. As Chief Medical Officer

Ritter Pharmaceuticals Appoints AnnKatrin Petersen-Jappelli, M.D., M.SC. As Chief Medical Officer

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (Ritter Pharmaceuticals or the Company), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases,...

Ritter Pharmaceuticals To Present At The 2015 Aegis Growth Conference

Ritter Pharmaceuticals To Present At The 2015 Aegis Growth Conference

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (Ritter Pharmaceuticals or the Company), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases,...

Ritter Pharmaceuticals To Present At The 3rd Microbiome R&D Business Collaboration Forum

Ritter Pharmaceuticals To Present At The 3rd Microbiome R&D Business Collaboration Forum

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (Ritter), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that the...

3 Breakout Stocks Under $10 to Trade Now

3 Breakout Stocks Under $10 to Trade Now

These under-$10 stocks are within range of triggering breakout trades.

Ritter Pharmaceuticals, Inc. Announces Closing Of $20,000,000 Initial Public Offering

Ritter Pharmaceuticals, Inc. Announces Closing Of $20,000,000 Initial Public Offering

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases with its lead product, RP-G28, being...

Ritter Pharmaceuticals, Inc. Announces Pricing Of Initial Public Offering

Ritter Pharmaceuticals, Inc. Announces Pricing Of Initial Public Offering

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases with its lead product, RP-G28, being...